Work

EDP-514, a novel pangenotypic class II hepatitis B virus core inhibitor: preliminary results of a phase 1 study in healthy adult subjects

Year: 2020

Type: article

Source: Journal of Hepatology

DOI: 10.1016/s0168-8278(20)32185-1

Authors: Kajal Larson, Alaa Ahmad, Eoin Coakley, Jingwen Chai, Daniel Dickerson, Nathalie Adda

Institutions: Enanta Pharmaceuticals (United States), PRA Health Sciences

Language: English

Topic: Hepatitis B Virus Studies

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4251267730

FWCI: 0.179

Cites:

Cited by: 1

Related to: 10